| Date | Title | Description | Source |
| 23.01.2024 | Ahead of Medicare drug price reform, pharma’s drug pricing h... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 12.01.2024 | 7 JPM Announcements You Don’t Want to Miss | This year’s J.P. Morgan Healthcare Conference in San Francisco, which wrapped on Thursday, enabled h... | medcitynew... |
| 05.12.2023 | Carmot’s chance of beating the odds in the biotech market ju... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 17.10.2023 | As Pfizer slashes revenue projections, Moderna says it “rema... | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
| 09.08.2023 | 2 recession-proof stocks for 2023 | The economy often moves in cycles of expansion and contraction. Contracting markets are also known a... | finbold.co... |
| 18.10.2022 | J&J holds off on volatile M&A market but has plent... | While J&J racked up $23 billion in total sales for the third quarter and spun off its consum... | endpts.com... |
| 20.04.2021 | JOHNSON & JOHNSON
Johnson & Johnson : Reports 2021 ... | New Brunswick, N.J. (April 20, 2021) - Johnson & Johnson (NYSE: JNJ) today announced results for... | marketscre... |
| 14.08.2020 | Backed by Johnson & Johnson, Thirty Madison Raises $47M ... | What You Should Know:
– Direct-to-consumer telehealth company Thirty Madison raises $47M in Series ... | hitconsult... |
| 12.03.2020 | Thermo Fisher, J&J partner on next-generation sequencing... | “The ability of the Oncomine Dx Target Test to rapidly detect variants of interest from very small q... | medcitynew... |
| 16.12.2019 | Mauna Kea Technologies Announces Equity Investment of €7.5 M... | PARIS & BOSTON--(BUSINESS WIRE)--Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY) (Euronext: MK... | citybizlis... |
| 25.07.2018 | Philadelphia’s digital health ecosystem takes shape | In an interview with Tom Olenzak, Managing Director for Independence Blue Cross’s Strategic Innovati... | medcitynew... |
| 18.03.2018 | Johnson & Johnson Announces Binding Offer from Platinum ... | Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum... | citybizlis... |
| 07.08.2017 | Houston Biotech Oncolix Announces Reverse Merger, Goes Publi... | Share Share on Facebook Share on Twitter LinkedIn Email Reprints
[Updated 8/7/17, 10:25 am. See bel... | xconomy.co... |
| 17.11.2016 | J&J takes one of its top blockbuster prospects to the F... | MorphoSys CSO Marlies Sproll
Hot on the heels of a new round of Phase III data showing that th... | endpts.com... |
| 31.10.2016 | How J&J’s Walmart relationship is inspiring its device b... | The Affordable Care Act has laid the groundwork for a seismic shift in the way the medical device in... | medcitynew... |
| 28.10.2016 | Should J&J buy Edwards Lifesciences? | In the Medical Devices, as you know we have a very strong presence in orthopaedics and in general su... | medcitynew... |
| 29.05.2015 | Johnson and Johnson accepts $2B offer for vascular medical d... | Otsuka Pharmaceutical Co Ltd lost a lawsuit challenging the U.S. Food and Drug Administration’s deci... | medcitynew... |
| 28.05.2015 | J&J accepts binding offer from Cardinal Health for Cordi... | Johnson & Johnson (NYSE:JNJ) said today that it accepted a binding offer worth about $2 billion ... | massdevice... |
| 14.04.2015 | Pharma the lone Q1 bright spot for J&J | Johnson & Johnson (NYSE:JNJ) today said the effect of a stronger dollar pared 13.2% from its top... | massdevice... |
| 01.04.2015 | Johnson & Johnson Innovation – JJDC Makes $15 Million In... | - | jnjinnovat... |
| 02.03.2015 | J&J deals Cordis to Cardinal Health for nearly $2B | Healthcare giant Johnson & Johnson (NYSE:JNJ) confirmed today that it plans to deal its Cordis s... | massdevice... |
| 23.09.2014 | Surgical startup raises $25M for ablation device that reduce... | Minerva has steadily raised a significant amount of capital since its 2008 launch – including this l... | medcitynew... |
| 22.07.2014 | Johnson & Johnson launches $5B buyback | Johnson & Johnson (NYSE:JNJ) last night announced that its board of directors approved a $5 bill... | massdevice... |
| 01.04.2014 | Carlyle officially wins Johnson & Johnson’s diagnostics ... | Johnson & Johnson (NYSE:JNJ) said late yesterday that it accepted a $4 billion offer from privat... | massdevice... |
| 26.03.2014 | The 2014 Midas List: Fewer New Names And More Explosive Exit... | For the third straight year, the number of newcomers to the Midas List has dropped. From 38 new name... | forbes.com... |
| 16.07.2013 | Johnson & Johnson’s medical device business misses Q2 ex... | Johnson & Johnson‘s (NYSE:JNJ) medical device & diagnostics segment missed Wall Street’s 2nd... | massdevice... |
| 16.07.2013 | Johnson & Johnson’s Q2 earnings soar 172% | Shares of Johnson & Johnson (NYSE:JNJ) could spike today after the healthcare giant reported sur... | massdevice... |
| 28.06.2013 | Shipping up to Boston: Johnson & Johnson debuts new Inno... | Johnson & Johnson (NYSE:JNJ) threw open the doors and cracked champagne at last night’s grand op... | massdevice... |
| 16.10.2012 | FLASH: Johnson & Johnson reports Q3 earnings slip 18%, b... | Johnson & Johnson (NYSE:JNJ) beat Wall Street’s earnings expectations and boosted its profit out... | massdevice... |
| 18.04.2012 | DePuy ASR recall takes $271M from J&J’s Q1 bottom line | Shares of Johnson & Johnson (NYSE:JNJ) closed up a hair yesterday after the company said it adde... | massdevice... |
| 03.04.2012 | Biomet offers $280M to acquire DePuy Orthopaedics’ trauma bu... | Biomet, meanwhile, just dodged a bullet of its own by agreeing to a $22 million settlement regarding... | medcitynew... |
| 10.02.2012 | DePuy Orthopaedics rolls out new hip, shoulder, knee surgery... | Knee surgery
The newly released AOX Antioxidant Polyethylene is a new formulation of polyethylene, ... | medcitynew... |
| 24.01.2012 | Johnson & Johnson takes $3 billion charge in 4Q over lit... | The company had only $218 million in profits on sales of $16.2 billion.
Last year, the company exit... | medcitynew... |
| 19.07.2011 | J&J’s Q2 earnings slide 20 percent, but it still beats T... | Johnson & Johnson (NYSE:JNJ) managed to top Wall Street’s expectations with its second-quarter r... | massdevice... |
| 25.01.2011 | Medical device unit can’t overcome JNJ recall woes | How do you spell relief?
For Johnson & Johnson (NYSE:JNJ), which has been battered for months b... | massdevice... |
| 19.10.2010 | J&J’s Cordis sees 35% drop in stent sales in third quart... | Taken together, however, Johnson & Johnson’s medical device and diagnostics segment managed to e... | medcitynew... |
| 28.09.2010 | Johnson & Johnson closes $480 million deal for Micrus En... | Johnson & Johnson (NYSE:JNJ) closed its $480 million cash deal to acquire Micrus Endovascular Co... | massdevice... |
| 12.07.2010 | Startup Devicor Medical buys Johnson & Johnson breast ca... | The former Ethicon Endo-Surgery breast care portfolio is sold in 50 countries and includes the Mammo... | medcitynew... |
| 04.06.2010 | Johnson & Johnson: Cordis Corp. is our only medical devi... | Johnson & Johnson (NYSE:JNJ) provided investors and analysts with a glimpse into its medical dev... | massdevice... |
| 18.05.2010 | FDA warns St. Jude Medical on improper cardiac catheter prom... | By Brandon Glenn
The Food & Drug Administration sent a warning letter to St. Jude Medical Inc. ... | massdevice... |
| 26.01.2010 | Johnson & Johnson’s Q4 net slumps 19 percent on restruct... | The $1 billion Johnson & Johnson (NYSE:JNJ) spent on restructuring during the fourth quarter exa... | massdevice... |
| 10.12.2009 | Second state AG subpoenas Medtronic | Medtronic Inc. (NYSE:MDT) said California attorney general Jerry Brown is demanding documents from i... | massdevice... |
| 04.11.2009 | Johnson & Johnson plans to cut up to 7 percent of global... | Promoted
This Patient Experience Checklist Is Your Key To Success in 2021
As healthcare systems st... | medcitynew... |
| - | Startup Devicor Medical buys Johnson & Johnson breast ca... | Devicor Medical Products Inc., the Pleasant Valley, Wisconsin, fledgling holding company backed by C... | medcitynew... |
| - | Johnson & Johnson narrowly tops quarterly estimates as p... | Johnson & Johnson reported fourth-quarter earnings and revenue that narrowly edged out Wall Stre... | cnbc.com/2... |
| - | Johnson & Johnson plans to cut up to 7 percent of global... | Image by Getty Images via Daylife
NEW BRUNSWICK, New Jersey – Health-products behemoth Johnson &a... | medcitynew... |
| - | Biomet offers $280M to acquire DePuy Orthopaedics’ trauma bu... | Biomet Inc. has made a $280 million binding offer to acquire the worldwide trauma business of Johnso... | medcitynew... |
| - | J&J’s Cordis sees 35% drop in stent sales in third quart... | Cordis Corp., the stent-making operation of Johnson & Johnson (NYSE:JNJ), saw overall sales slip... | medcitynew... |
| - | Thermo Fisher, J&J partner on next-generation sequencing... | A unit of Johnson & Johnson is working with one of the country’s largest makers of diagnostics a... | medcitynew... |
| - | How J&J’s Walmart relationship is inspiring its device b... | The Affordable Care Act has laid the groundwork for a seismic shift in the way the medical device in... | medcitynew... |
| - | Surgical startup raises $25M for ablation device that reduce... | Bay Area startup Minerva Surgical has just raised $25 million for its device that treats menorrhagia... | medcitynew... |
| - | Philadelphia’s digital health ecosystem takes shape | This article is sponsored by the CEO Council for Growth, an initiative of the Chamber of Commerce fo... | medcitynew... |
| - | DePuy Orthopaedics rolls out new hip, shoulder, knee surgery... | DePuy Orthopaedics launched several new surgical products this week for knee, shoulder and hip revis... | medcitynew... |
| - | Should J&J buy Edwards Lifesciences? | Last week, in an earnings call with analysts, Dominic Caruso, chairman and CEO of Johnson & John... | medcitynew... |
